NetworkNewsBreaks – Assembly Biosciences Inc. (NASDAQ: ASMB) Featured in Mizuho Securities Research Report
Assembly Biosciences (NASDAQ: ASMB) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Assembly released its 1Q21 results after the bell, and we had a chance to catch up with management this evening. The new information is incremental in nature in that we're getting some in-the-weeds data at EASL. It likely won't change the overall picture of the ASMB story or answer the finite therapy question, but it's something to look forward to for anybody deep in HBV in what has mostly been a quiet first half for the stock. FWIW --…







